In addition, NLRP6 and NLRP3 ablation has been associated with a worsening of multiple aspects of the metabolic syndrome, including obesity, via modulation of gut microbiota. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.